- Report
- March 2025
- 50 Pages
Global
From €2529EUR$2,650USD£2,119GBP
Pancuronium is a neuromuscular blocking agent used in the treatment of Central Nervous System (CNS) drugs. It is a synthetic, non-depolarizing muscle relaxant that works by blocking the transmission of nerve impulses to the muscles, resulting in paralysis. Pancuronium is used in a variety of medical procedures, including general anesthesia, intubation, and mechanical ventilation. It is also used to facilitate the insertion of a breathing tube into the trachea.
Pancuronium is available in both generic and branded forms. It is typically administered intravenously and is available in a variety of concentrations and dosages. The most common side effects associated with pancuronium include nausea, vomiting, and hypotension.
The pancuronium market is highly competitive, with a number of companies offering products. Some of the major players in the market include Mylan, Pfizer, Teva Pharmaceuticals, and Hospira. Show Less Read more